Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

DERIC SAVIOR

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1912183765
CMS profile
313459
Location
WYNNEWOOD, PA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$51,672.39

223 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

By paying entity

PY2024 · entire year · sorted by reported total

Paying entityAmountRecords
Regeneron Healthcare Solutions, Inc. $24,033.32 30
JAZZ PHARMACEUTICALS INC. $8,611.80 12
Janssen Biotech, Inc. $5,422.75 14
Regeneron Pharmaceuticals, Inc. $3,837.20 4
Fosun Pharma USA Inc. $3,820.09 2
Bayer Healthcare Pharmaceuticals Inc. $1,782.05 5
AstraZeneca Pharmaceuticals LP $547.60 16
Novartis Pharmaceuticals Corporation $317.63 15
Genentech USA, Inc. $244.67 10
Dendreon Pharmaceuticals LLC $224.22 2
Merck Sharp & Dohme LLC $198.61 5
Astellas Pharma US Inc $195.87 10
Eisai Inc. $178.03 7
PFIZER INC. $157.66 9
Lilly USA, LLC $156.18 3
Alexion Pharmaceuticals, Inc. $140.27 5
Incyte Corporation $124.94 5
Takeda Pharmaceuticals U.S.A., Inc. $124.01 5
Daiichi Sankyo Inc. $119.23 5
E.R. Squibb & Sons, L.L.C. $118.13 4
Gilead Sciences, Inc. $112.55 1
Ipsen Biopharmaceuticals, Inc $84.65 3
GENZYME CORPORATION $80.97 2
GlaxoSmithKline, LLC. $77.30 4
Celgene Corporation $65.87 3
Tempus AI, Inc $60.91 3
ABBVIE INC. $57.83 2
SOBI, INC $54.84 3
EMD Serono, Inc. $50.82 2
BeiGene USA, Inc. $49.92 2
Blueprint Medicines Corporation $45.58 2
Stemline Therapeutics Inc. $43.14 2
TerSera Therapeutics LLC $41.88 2
PUMA BIOTECHNOLOGY, INC. $41.47 2
Genmab U.S., Inc. $39.74 2
ARRAY BIOPHARMA INC $39.34 2
Immunocore Limited $37.51 1
Exelixis Inc. $33.50 2
Cumberland Pharmaceuticals, Inc. $33.35 2
ImmunoGen, Inc. $29.96 1
Karyopharm Therapeutics Inc. $25.42 1
Deciphera Pharmaceuticals Inc. $24.34 1
Fennec Pharmaceuticals, Inc. $23.04 1
Novocure Inc. $22.75 1
Amgen Inc. $21.73 1
Rigel Pharmaceuticals, Inc. $20.62 1
Aveo Pharmaceuticals, Inc. $20.28 1
Acrotech Biopharma Inc. $19.02 1
Sumitomo Pharma America, Inc. $16.18 1
Pharmacosmos Therapeutics Inc. $15.44 1
Secura Bio, Inc. $14.53 1
Coherus Biosciences Inc. $13.65 1

Page 3 of 5; records 101–150 of 223 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

DERIC SAVIOR

NPI 1912183765 · CMS profile ID 313459

Allopathic & Osteopathic Physicians / Internal Medicine / Medical Oncology

WYNNEWOOD, PA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 5; records 101–150 of 223 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1912183765?year=2024&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
DERIC SAVIOR, NPI 1912183765, CMS profile ID 313459. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 5; records 101–150 of 223 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1912183765?year=2024&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). DERIC SAVIOR, NPI 1912183765, CMS profile ID 313459. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 5; records 101–150 of 223 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1912183765?year=2024&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
DERIC SAVIOR, NPI 1912183765, CMS profile ID 313459, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 5; records 101–150 of 223 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1912183765?year=2024&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

223 matching records · $51,672.39 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 223 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–150 of 223.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
GlaxoSmithKline, LLC. $20.6008/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1116271784 CMS
Lilly USA, LLC $18.6708/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1136164852 CMS
PFIZER INC. $19.7608/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131350643 CMS
AstraZeneca Pharmaceuticals LP $31.1208/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105587210 CMS
Ipsen Biopharmaceuticals, Inc $30.4908/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1091959274 CMS
Exelixis Inc. $20.0108/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1138557149 CMS
Lilly USA, LLC $24.8608/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1136144055 CMS
Novartis Pharmaceuticals Corporation $21.9908/02/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087248103 CMS
PFIZER INC. $18.7808/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131369195 CMS
GlaxoSmithKline, LLC. $21.2007/31/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1116620851 CMS
Genentech USA, Inc. $24.0407/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1133001177 CMS
Janssen Biotech, Inc. $24.6407/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078607933 CMS
Novartis Pharmaceuticals Corporation $16.8807/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087248101 CMS
Tempus AI, Inc $19.4207/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1150173858 CMS
Novartis Pharmaceuticals Corporation $29.5707/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087248099 CMS
E.R. Squibb & Sons, L.L.C. $32.2907/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101219048 CMS
Regeneron Healthcare Solutions, Inc. $25.1607/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1114157652 CMS
Genmab U.S., Inc. $19.7807/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1126825989 CMS
Regeneron Healthcare Solutions, Inc. $21.4207/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1114157648 CMS
Novartis Pharmaceuticals Corporation $23.5707/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087248097 CMS
Blueprint Medicines Corporation $21.4807/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1147440488 CMS
Astellas Pharma US Inc $21.5107/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139276406 CMS
AstraZeneca Pharmaceuticals LP $111.7807/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105898106 CMS
ARRAY BIOPHARMA INC $18.3607/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131700456 CMS
Cumberland Pharmaceuticals, Inc. $18.6707/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1146403466 CMS
Regeneron Pharmaceuticals, Inc. $118.4506/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1114404543 CMS
Fosun Pharma USA Inc. $3,600.0006/25/2024 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1146938680 CMS
Fosun Pharma USA Inc. $220.0906/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1146938682 CMS
Daiichi Sankyo Inc. $19.8106/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1089478795 CMS
Incyte Corporation $28.4706/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141321955 CMS
Genentech USA, Inc. $25.0006/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1133001174 CMS
TerSera Therapeutics LLC $26.5306/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1144713919 CMS
Novartis Pharmaceuticals Corporation $18.5906/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087248095 CMS
JAZZ PHARMACEUTICALS INC. $38.4106/02/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1150237850 CMS
JAZZ PHARMACEUTICALS INC. $141.0306/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1150237854 CMS
Eisai Inc. $22.7805/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1110741583 CMS
BeiGene USA, Inc. $28.7105/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1120852412 CMS
SOBI, INC $19.1805/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141422427 CMS
Genentech USA, Inc. $19.9905/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1133001170 CMS
Takeda Pharmaceuticals U.S.A., Inc. $29.8905/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1144966701 CMS
Astellas Pharma US Inc $14.5305/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139337644 CMS
PFIZER INC. $24.4705/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131314303 CMS
Stemline Therapeutics Inc. $19.3605/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1142959434 CMS
Astellas Pharma US Inc $15.6205/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139333018 CMS
Novartis Pharmaceuticals Corporation $21.7305/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087248093 CMS
AstraZeneca Pharmaceuticals LP $26.9105/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105393920 CMS
PFIZER INC. $22.2205/02/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131330547 CMS
Celgene Corporation $18.9204/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101081841 CMS
Ipsen Biopharmaceuticals, Inc $34.8304/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1091959270 CMS
Daiichi Sankyo Inc. $27.0604/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1089478793 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $37,036.11 42
PY2020 $29,304.65 21
PY2021 $67,665.15 58
PY2022 $36,554.73 127
PY2023 $51,787.96 189
PY2024 $51,672.39 223
PY2025 $69,296.15 232

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $51,350.00 3

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

3 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Janssen Research & Development, LLC $950.00 07/08/2025 Non-covered Recipient Entity
LANKENAU INSTITUTE FOR MEDICAL RESE ARCH
A Phase 2b, Open-Label, Two-cohort Study of Subcutaneous Amivantamab in Combination with Lazertinib as First-Line Treatment, or Subcutaneous Amivantamab in Combination with Platinum-Based Chemotherapy as Second-line Treatment, for Common EGFR-Mutated Loc No dispute reported 06/30/2026 1175342374
Principal investigator 1 Janssen Research & Development, LLC $14,000.00 07/04/2025 Non-covered Recipient Entity
LANKENAU INSTITUTE FOR MEDICAL RESE ARCH
A Phase 2b, Open-Label, Two-cohort Study of Subcutaneous Amivantamab in Combination with Lazertinib as First-Line Treatment, or Subcutaneous Amivantamab in Combination with Platinum-Based Chemotherapy as Second-line Treatment, for Common EGFR-Mutated Loc No dispute reported 06/30/2026 1175342381
Principal investigator 1 Janssen Research & Development, LLC $36,400.00 06/16/2025 Non-covered Recipient Entity
LANKENAU INSTITUTE FOR MEDICAL RESE ARCH
A Phase 2b, Open-Label, Two-cohort Study of Subcutaneous Amivantamab in Combination with Lazertinib as First-Line Treatment, or Subcutaneous Amivantamab in Combination with Platinum-Based Chemotherapy as Second-line Treatment, for Common EGFR-Mutated Loc No dispute reported 06/30/2026 1175342368